AOP Health Starts Research for Leukemia Treatment

August 1, 2022

AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in the longer term. Agnes Kohl, Chief Business Officer, AOP Orphan Pharmaceuticals GmbH, Member of the […]